We are live on ! Find out more
GMED icon

Globus Medical

166 hedge funds and large institutions have $1.13B invested in Globus Medical in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 56 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

16% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 56

0.67% less ownership

Funds ownership: 82.71%82.04% (-0.67%)

5% less funds holding

Funds holding: 175166 (-9)

15% less capital invested

Capital invested by funds: $1.33B → $1.13B (-$197M)

20% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 35

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

54% less call options, than puts

Call options by funds: $124K | Put options by funds: $272K

Holders
166
Holders Change
-9
Holders Change %
-5.14%
% of All Funds
4.82%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
28
Increased
65
Reduced
56
Closed
35
Calls
$124K
Puts
$272K
Net Calls
-$148K
Net Calls Change
-$190K
Name Holding Trade Value Shares
Change
Change in
Stake
Thrivent Financial for Lutherans
101
Thrivent Financial for Lutherans
Minnesota
$715K -$1.05M -50,950 -58%
MC
102
Menta Capital
California
$710K +$743K +36,100 New
BA
103
BlackRock Advisors
Delaware
$708K -$12.4K -602 -2%
PAAMCP
104
Pacific Alternative Asset Management Company (PAAMCO)
California
$649K +$679K +32,988 New
AA
105
ALPS Advisors
Colorado
$596K +$623K +30,300 New
Calamos Advisors
106
Calamos Advisors
Illinois
$588K +$198K +9,600 +47%
VOYA Investment Management
107
VOYA Investment Management
Georgia
$560K
NI
108
Numeric Investors
Massachusetts
$551K +$576K +28,000 New
LPL Financial
109
LPL Financial
California
$546K +$78.4K +3,812 +16%
ProShare Advisors
110
ProShare Advisors
Maryland
$514K -$122K -5,920 -18%
D.E. Shaw & Co
111
D.E. Shaw & Co
New York
$509K -$4.5M -218,567 -89%
PSC
112
Piper Sandler & Co
Minnesota
$492K +$514K +25,000 New
CB
113
Commerce Bank
Missouri
$478K +$87.8K +4,265 +21%
Connor, Clark & Lunn Investment Management (CC&L)
114
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$447K -$18.5K -900 -4%
Goldman Sachs
115
Goldman Sachs
New York
$443K -$261K -12,702 -36%
Royal Bank of Canada
116
Royal Bank of Canada
Ontario, Canada
$424K +$439K +21,345 +9,974%
GCP
117
GSA Capital Partners
United Kingdom
$418K +$93.6K +4,551 +27%
ZL
118
Zeke LP
Pennsylvania
$393K +$411K +20,000 New
U
119
UBS
Switzerland
$388K +$51K +2,477 +14%
Deutsche Bank
120
Deutsche Bank
Germany
$382K -$2.62M -127,532 -87%
OAM
121
Oxford Asset Management
United Kingdom
$380K +$396K +19,256 New
UBS AM
122
UBS AM
Illinois
$368K
ECM
123
ETrade Capital Management
Virginia
$340K +$167K +8,141 +89%
QI
124
Quotient Investors
New York
$317K +$331K +16,100 New
Fifth Third Bancorp
125
Fifth Third Bancorp
Ohio
$311K -$17K -826 -5%

GMED Hedge Fund Activity: Q3 2014 in Review

166 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q3 2014, worth a combined $1.13B — down 15% from $1.33B a quarter earlier.

Sellers outnumbered buyers: 35 funds closed out of GMED and 28 opened new positions — a net loss of 7 holders — while 56 trimmed existing stakes and 65 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $26.3M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $31.9M sold.

  • 166 institutional investors held Globus Medical (GMED) as of Q3 2014, down from 175 in Q2 2014.
  • Funds reported $1.13B of Globus Medical stock for Q3 2014, down 15% quarter-over-quarter.
  • 28 funds opened new Globus Medical positions in Q3 2014 and 35 closed out, a net change of -7 holders.
  • The largest Globus Medical buyer in Q3 2014 was Deerfield Management, an estimated $26.3M added.
  • The largest Globus Medical seller in Q3 2014 was OppenheimerFunds, an estimated $31.9M sold.

Based on aggregated 13F filings for Q3 2014.